Literature DB >> 18583324

Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model.

Takamitsu Sasaki1, Toru Nakamura, Robert B Rebhun, Hua Cheng, Katherine Stemke Hale, Rachel Z Tsan, Isaiah J Fidler, Robert R Langley.   

Abstract

The transforming growth factor alpha (TGFalpha)/epidermal growth factor receptor (EGFR) signaling pathway appears to play a critical role in colon cancer progression, but the cellular and molecular mechanisms that contribute to metastasis remain unknown. KM12C colon cancer cell clones expressing high (C9) or negligible (C10) levels of TGFalpha were implanted into the cecal walls of nude mice. C9 tumors formed autocrine and paracrine EGFR networks, whereas C10 tumors were unable to signal through EGFR. The tumor microenvironment of C9, but not C10, contained cells enriched in vascular endothelial growth factor (VEGF) A, interleukin-8, and matrix metalloproteinases-2 and -9 and had a high vascular surface area. C9 tumors recruited a macrophage population that co-expressed F4/80 and lymphatic vessel endothelial hyaluronic acid receptor and produced VEGFC. The mean lymphatic density of C9 tumors was threefold higher than that of C10 tumors. C9, but not C10, tumor cells metastasized to regional lymph nodes in all mice and to the liver in 5 of 10 mice. Forced expression of TGFalpha in C10 tumor cells led to the generation of autocrine and paracrine EGFR signaling, macrophage recruitment, enhanced blood and lymphatic vascular surface areas, and increased lymphatic metastasis. Collectively, these data show that activation of TGFalpha-EGFR signaling in colon cancer cells creates a microenvironment that is conducive for metastasis, providing a rationale for efforts to inhibit EGFR signaling in TGFalpha-positive colon cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583324      PMCID: PMC2438298          DOI: 10.2353/ajpath.2008.071147

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  66 in total

Review 1.  The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature.

Authors:  Guillermo Oliver; Michael Detmar
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

Review 2.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Authors:  Lynn Hlatky; Philip Hahnfeldt; Judah Folkman
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

Review 3.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

4.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.

Authors:  L A Liotta; J Kleinerman; G M Saidel
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Structural alterations of the epidermal growth factor receptor gene in human gliomas.

Authors:  A J Wong; J M Ruppert; S H Bigner; C H Grzeschik; P A Humphrey; D S Bigner; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.

Authors:  Dongfang Wang; Richard E Lehman; David B Donner; Mary R Matli; Robert S Warren; Mark L Welton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-06       Impact factor: 4.052

7.  Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel.

Authors:  Chiara Barozzi; Matteo Ravaioli; Antonia D'Errico; Gian Luca Grazi; Gilberto Poggioli; Giulia Cavrini; Alighieri Mazziotti; Walter Franco Grigioni
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

8.  Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts.

Authors:  Monique C A Duyndam; Marion C G W Hilhorst; Hennie M M Schlüper; Henk M W Verheul; Paul J van Diest; Georg Kraal; Herbert M Pinedo; Epie Boven
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

9.  Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium.

Authors:  S D Markowitz; K Molkentin; C Gerbic; J Jackson; T Stellato; J K Willson
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

10.  Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.

Authors:  Kazuichi Maruyama; Jun Asai; Masaaki Ii; Tina Thorne; Douglas W Losordo; Patricia A D'Amore
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more
  18 in total

Review 1.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

2.  Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.

Authors:  Edmund Chiong; I-Ling Lee; Ali Dadbin; Anita L Sabichi; Loleta Harris; Diana Urbauer; David J McConkey; Rian J Dickstein; Tiewei Cheng; H Barton Grossman
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

Review 3.  The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

Review 4.  From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

Review 5.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

6.  A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies.

Authors:  Michihiro Yoshida; Takaya Shimura; Mikinori Sato; Masahide Ebi; Takahiro Nakazawa; Hiromitsu Takeyama; Takashi Joh
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-26       Impact factor: 4.553

7.  Fusion between cancer cells and myofibroblasts is involved in osteosarcoma.

Authors:  Ling Yu; Weichun Guo; Shenghao Zhao; Fuan Wang; Yong Xu
Journal:  Oncol Lett       Date:  2011-07-14       Impact factor: 2.967

Review 8.  Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.

Authors:  H Michael Shepard; Cathleen M Brdlik; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

9.  HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.

Authors:  Menghong Sun; Carmen Behrens; Lei Feng; Natalie Ozburn; Ximing Tang; Guosheng Yin; Ritsuko Komaki; Marileila Varella-Garcia; Waun Ki Hong; Kenneth D Aldape; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

10.  Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis.

Authors:  Fang Yan; Hanwei Cao; Rupesh Chaturvedi; Uma Krishna; Stuart S Hobbs; Peter J Dempsey; Richard M Peek; Timothy L Cover; M Kay Washington; Keith T Wilson; D Brent Polk
Journal:  Gastroenterology       Date:  2009-01-01       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.